Bio-Thera Solutions, Ltd. Class A · SSE:688177

Bio-Thera Solutions, Ltd. Class A financial statements

Bio-Thera Solutions, Ltd. Class A's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in CNY

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue935.2M743.2M704.8M455.1M836.6M185.0M700.0K02.01M2.76M
Cost of revenue197.2M229.5M193.3M190.6M35.6M19.9M127.8K722.7K1.92M
Gross profit738.0M513.6M511.5M264.5M801.0M165.1M572.3K01.29M842.0K
Research and development800.2M777.6M768.6M616.4M543.4M562.7M636.5M541.7M236.5M131.5M
Selling, general and administrative273.3M215.5M102.8M153.7M194.4M143.2M32.6M8.94M5.82M4.81M
Operating income-346.3M-496.0M-392.6M-494.6M84.3M-546.6M-1.02B-553.7M-239.1M-143.6M
Depreciation and amortization104.3M89.4M85.2M83.8M72.9M59.0M55.5M49.5M23.0M5.23M
EBITDA-242.0M-406.6M-307.3M-410.8M157.2M-487.7M-969.3M-504.2M-216.1M-138.4M
Interest expense20.1M20.6M10.4M61.9K775.4K3.70M770.0K27.8K00
Income before tax-331.6M-510.3M-394.4M-480.4M91.0M-513.2M-1.02B-553.1M-235.5M-136.6M
Income tax2.13K9.11M
Net income-331.9M-510.3M-394.5M-480.4M81.9M-513.2M-1.02B-553.1M-235.5M-136.6M
Earnings per share, basic-0.80-1.23-0.95-1.160.20-1.24-2.89-1.56-0.67

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents218.6M289.8M164.0M165.9M847.5M283.5M39.1M112.4M33.4M8.42M
Short-term investments90.2M331.0M629.9M602.8M955.8M
Receivables164.7M104.1M148.7M89.8M103.3M55.4M1.11M986.2K11.0M2.25M
Inventory312.4M253.1M231.2M161.9M90.1M45.9M43.6M36.7M7.87M2.14M
Current assets958.6M888.0M1.01B1.16B1.77B1.47B177.8M217.3M120.8M332.2M
Property, plant and equipment693.9M579.4M581.7M425.4M417.9M427.4M300.2M
Total assets2.29B2.21B2.29B2.18B2.62B2.39B1.01B1.02B618.9M708.3M
Accounts payable198.7M199.5M171.5M83.8M45.7M84.8M153.5M99.1M111.4M116.2M
Current liabilities1.37B1.10B725.4M538.5M526.0M385.4M380.5M213.2M271.0M173.3M
Long-term debt374.2M370.4M323.8M3.00M
Total liabilities1.91B1.50B1.07B572.5M530.3M387.6M383.7M219.4M271.4M173.9M
Shareholders' equity376.0M708.1M1.21B1.61B2.09B2.01B630.7M801.3M347.6M534.4M
Shares outstanding414.1M414.1M414.1M414.1M414.1M414.1M354.1M354.1M354.1M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-82.1M-55.7M-460.9M-412.8M236.3M-358.0M-598.0M-528.2M-236.7M-116.2M
Capital spending-121.7M-126.8M-275.9M-258.8M-77.9M-253.3M-74.8M-317.8M-160.8M-119.2M
Free cash flow-203.9M-182.5M-780.3M-671.6M158.4M-611.3M-672.8M-846.0M-397.5M-235.4M
Cash from investing-245.8M301.8M-1.18B-74.8M-339.3M-145.6M-119.1M
Cash from financing-30.2M26.5M1.78B599.3M933.0M99.0M
Dividends paid-20.4M-20.6M-5.67M-164.5K-553.0K-3.85M-620.6K-620.6K-620.6K
Change in cash-50.1M150.9M169.4M-688.0M563.8M244.2M-73.5M65.4M-283.2M311.4M